Sunday, October 20, 2019
7:00 – 8:15 am
Improving Transfusion Safety: Scalable Solutions for routine to molecular blood typing
- Features of a new licensed genotyping platform for improving transfusion safety
Connie M. Westhoff, SBB, PhD. Executive Scientific Director, Immunohematology and Genomics, New York Blood Center Enterprises, NY.
- Experience with a new adaptable analyzer: how automation can meet the needs of a busy modern immunohematology laboratory
Jeremy C. Parsons, MD. Tricore Reference Laboratories, Albuquerque, NM, and Pathology Associates of Albuquerque, Albuquerque, NM.
Summary of Presentations
Modern IH labs face increasing workloads and complexity, requiring a refocus on automation to address new challenges in molecular and serological testing. Modern analyzers should offer standardized and sensitive testing, be flexible, and adaptable to new demands. This workshop shares results and experiences of clinical trials supporting the FDA licensure of two systems that meet these new needs.
Monday, October 21, 2019
7:00 – 8:15 am
Transfusion Transmission Infectious Agent Threats: Known and Unknown
- Eric Delwart, Ph.D. Senior Investigator, Vitalant Research Institute, San Francisco, California
- Phillip Williamson, Ph.D. Chief Scientific Officer, Creative Testing Solutions, Phoenix, Arizona
- Jeffrey Linnen, Ph.D. Vice President, Research and Development, Grifols Diagnostics Solutions Inc., San Diego, California
Summary of Presentation
Donor screening assay manufacturers must be vigilant concerning infectious diseases that threaten the global blood supply safety. This workshop will discuss:
- Current research in identifying future blood borne human infections, focusing on arboviruses
- Progress of Babesia parasite screening
- A commercial response of multiplex testing of emergent viruses, to support testing efficiency